Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply

Arch Neurol. 2012 Aug 1;69(8):1085-6. doi: 10.1001/archneurol.2012.1316.

Authors

Ingo Kleiter, Kerstin Hellwig, Achim Berthele, Tania Kümpfel, Ralf A Linker, Hans-Peter Hartung, Friedemann Paul, Orhan Aktas; Neuromyelitis Optica Study Group (NEMOS)

PMID: 23753805
DOI: 10.1001/archneurol.2012.1316

No abstract available